📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2022.104293

PubMed Identifier: 36182629

Publication URI: http://europepmc.org/abstract/MED/36182629

Type: Journal Article/Review

Volume: 85

Parent Publication: EBioMedicine

ISSN: 2352-3964